DrugDashboards

Fentanyl system

Fentanyl · FENTANYL 75 ug/1 · Patch · Transdermal · Alvogen

NDC 47781-0427-47 · 5 POUCH in 1 CARTON / 1 PATCH in 1 POUCH · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. The price is up 17% over the past year, to $15.44 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$15.44per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$11.10per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$15.44per TDPweighted avg manufacturer price $5.3590 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$10.00$20.00Dec 2016Sep 2026$15.44
118 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

WAC per package, as filed
$100.10
Reported to Texas DSHS · 2026 annual filing · Alvogen Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$233,668
1,891 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

20Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • 2 active manufacturers+20

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for fentanyl (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $112.51 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA202097
TE code
AB
Approval date
Nov 4, 2016
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class I · OngoingJan 31, 2025
    Alvogen, IncDefective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
  • Class I · TerminatedApr 19, 2019
    Alvogen, IncProduct Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.

Manufacturers of Fentanyl (Patch)

LabelerStrengthFirst seenLast seen
AlvogenFENTANYL 12.5 ug/1Jul 15, 2026Sep 2, 2026
AlvogenFENTANYL 25 ug/1Jul 15, 2026Sep 2, 2026
AlvogenFENTANYL 75 ug/1Jul 15, 2026Sep 2, 2026
AlvogenFENTANYL 50 ug/1Jul 15, 2026Sep 2, 2026
AlvogenFENTANYL 100 ug/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 50 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 62.5 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 75 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 87.5 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 100 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 12 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 25 ug/hJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.FENTANYL 37.5 ug/hJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Fentanyl system — NDC 47781-0427-47," retrieved September 3, 2026, https://drugdashboards.com/drug/47781042747.

Free to cite with attribution — see how the data is put together.